Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina

被引：0
|
作者：
Liliana Bezrodnik
Andrea Gómez Raccio
Gabriela Belardinelli
Lorena Regairaz
Damacia Díaz Ballve
Gisela Seminario
Ileana Moreira
Carlos Riganti
Claudio Cantisano
Héctor Díaz
Daniela Di Giovanni
机构：
[1] Inmunología,
[2] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
[3] Inmunología,undefined
[4] Hospital de Niños “Sor María Ludovica”,undefined
[5] Inmunología,undefined
[6] Hospital de Niños Pedro Elizalde,undefined
[7] Inmunología,undefined
[8] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
来源：
Journal of Clinical Immunology | 2013年 / 33卷
关键词：
Argentina; children; immunoglobulin therapy; intravenous; primary immunodeficiency; subcutaneous; Beriglobina P;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1216 / 1222
页数：6
相关论文
共 50 条
  • [11] Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose
    Berger, Melvin
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (06) : 532 - 538
  • [12] Pharmacokinetic Modeling and Simulation of Subcutaneous and Intravenous IgG Dosing in Primary Immunodeficiency Patients
    Navarro-Mora, Graciela
    Alberti, Joan
    Torres, Juan Vicente
    Ayguasanosa, Jaume
    Paez, Antonio
    Vilardell, David
    Mondou, Elsa
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S35 - S35
  • [13] Longitudinal study of intravenous versus subcutaneous immunoglobulin replacement therapy in hematological malignancy
    Windegger, Tanja M.
    English, Janine
    Weston, Helen
    Morwood, Karen
    Kynn, Mary
    Scuffham, Paul
    Fung, Yoke-Lin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 546 - 554
  • [14] Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases
    Haddad, Elie
    Barnes, David
    Kafal, Ayman
    TRANSFUSION AND APHERESIS SCIENCE, 2012, 46 (03) : 315 - 321
  • [15] Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
    Skoda-Smith, Suzanne
    Torgerson, Troy R.
    Ochs, Hans D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 1 - 10
  • [16] Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
    Kobrynski, Lisa
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 277 - 287
  • [17] Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases
    Mach-Tomalska, Monika
    Pituch-Noworolska, Anna
    Bien, Ewa
    Malanowska, Magdalena
    Machura, Edyta
    Pukas-Bochenek, Anna
    Chrobak, Ewelina
    Pac, Malgorzata
    Pietrucha, Barbara
    Drygala, Szymon
    Kamieniak, Marta
    Kasprzak, Jakub
    Heropolitanska-Pliszka, Edyta
    IMMUNOTHERAPY, 2024, 16 (06) : 391 - 403
  • [18] Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases
    Baumann, Ulrich
    Fasshauer, Maria
    Pausch, Christine
    Wittkowski, Helmut
    Hermann, Corinna
    Pittrow, David
    Borte, Michael
    IMMUNOTHERAPY, 2022, 14 (02) : 135 - 143
  • [19] The Construction of a Pharmacokinetic Model to Describe Intravenous and Subcutaneous Supplementation of IgG in Patients with Primary Immunodeficiency (PID)
    Bexon, M.
    Rojavin, M.
    Jolles, S.
    Ellis, S.
    Sawyer, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB16 - AB16
  • [20] Flebogamma® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases
    Mark Ballow
    Paul J. Pinciaro
    Timothy Craig
    Gary Kleiner
    James Moy
    Hans D. Ochs
    John Sleasman
    William Smits
    Journal of Clinical Immunology, 2016, 36 : 583 - 589
12345